Am J Transplant, Volume 22, Suppl 3 Archives - Page 5 of 190 - ATC Abstracts

2022 American Transplant Congress
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
¹Department of Surgery, University of California Los Angeles, Los Angeles, CA, ²Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA
*Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…
2022 American Transplant Congress
Effect of Abdominal Aortic Calcification on Renal Function After Liver Transplantation
R. Ide, M. Ohira, R. Arata, K. Imaoka, K. Ono, T. Mochizuki, N. Tsukiyama, A. Seidakhmetov, H. Yamane, K. Sato, Y. Imaoka, H. Mashima, D. Marlen, R. Nakano, M. Hashimoto, N. Tanimine, S. Kuroda, H. Tahara, K. Ide, T. Kobayashi, Y. Tanaka, H. Ohdan
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: In the wake of improvement in engraftment and survival rates after liver transplantation (LT) in Japan, the onset of late complications, such as renal…
2022 American Transplant Congress
Significance of C4d Expression in Peritubular Capillary Concurrent with Microvascular Inflammation in For-Cause Biopsies of ABO-Incompatible Renal Allografts
H. Cho¹, C. Baek², H. Kim³
¹Department of Pathology, Asan Medical Center, Seoul, Korea, Republic of, ²Department of Internal Medicine, Asan Medical Center, Seoul, Korea, Republic of, ³Asan Medical Center, Seoul, Korea, Republic of
*Purpose: ABO incompatible (ABOi) kidney transplantation (KT) has been increasing due to severe organ shortages. Pathologic diagnosis of antibody-mediated rejection (ABMR) in ABOi patients is…
2022 American Transplant Congress
Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor
J. M. Vanatta¹, R. A. Helmick², C. Eymard², N. Nezakatgoo², P. Horton², J. P. Kothadia², S. P. Nair², J. D. Eason²
¹Transplantation, University of Tennessee/Methodist University Hospital, Memphis, TN, ²Transplantation, University of Tennessee, Memphis, TN
*Purpose: Liver transplantation (LT) has emerged as a therapy in selected patients for neuroendocrine tumor (NET) by providing cytoreduction. Progression-free survival in NET has been…
2022 American Transplant Congress
The Implication of Donor Race on the Post-Liver Transplant Prognosis of Patients with Nonalcoholic Steatohepatitis: Analysis of UNOS Database
D. U. Lee¹, J. Han², J. Kwon², K. Chang², K. Lee², G. Fan², N. Urranaga¹, D. Maluf³, C. Bhati¹, K. Shetty¹
¹Department of Gastroenterology and Hepatology, University of Maryland, Baltimore, MD, ²Tufts Medical Center, Boston, MA, ³University of Maryland, Baltimore, MD
*Purpose: Prior studies have suggested liver transplant (LT) recipients who receive their grafts from minority donors may potentially suffer higher rates of graft complications. In…
2022 American Transplant Congress
Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient
J. Byrns¹, G. Katz-Greenberg²
¹Pharmacy, Duke University Hospital, Durham, NC, ²Medicine, Duke University Medical Center, Durham, NC
*Purpose: Cytomegalovirus (CMV) viremia is a common complication of kidney transplant recipients (KTR) with significant morbidity/mortality. Patients who receive multiple transplants are potentially at a…
2022 American Transplant Congress
Longitudinal Monitoring of Simultaneous Pancreas and Kidney Transplant and Pancreas After Kidney Recipients Using Donor-Derived Cell-Free DNA
N. M. Ali¹, J. Miles², Z. Stewart³
¹Transplant Institute, NYU Langone Health, New York, NY, ²CareDx, Brisbane, NY, ³Transplant Institute, NYU Langone Health, New York, NM
*Purpose: The utility of dd-cfDNA in patients undergoing pancreas transplantation has not been well studied. Pancreatic rejection remains a major clinical concern. Early identification of…
2022 American Transplant Congress
Long-Term Implication of Kidney Injury Prior to Liver Transplantation for Acute Liver Failure
M. R. Cloonan¹, D. J. Cloonan², S. Westphal³, L. A. Dageforde¹, S. Merani¹
¹Division of Transplant, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, ²Division of Transplant Surgery, Massachusetts General Hospital, Boston, MA, ³University of Nebraska Medical Center, Omaha, NE
*Purpose: Acute liver failure (ALF) is a heterogeneous disease process that often includes acute kidney injury. Long-term sequelae of kidney impairment in patients with ALF…
2022 American Transplant Congress
Analysis of Antibiotic Resistance and Risk Level of Preservation Fluid Microorganisms in Kidney Transplant Recipients
J. Li¹, X. Su¹, J. Han², Y. Huang², W. Wu¹, M. Wei², S. Yuan², C. Wu¹, J. Li¹, L. Liu¹, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Sun Yat-sen University, Guangzhou, China
*Purpose: As a solution for preserving kidney during procurement and transportation, preservation fluid (PF) is the main method to detect donor-derived infection. But there are…
2022 American Transplant Congress
Impact of Removing DSA and OPTN Region from Pancreas Allocation
S. E. Booker¹, A. Robinson¹, K. Gauntt¹, J. White¹, S. Niederhaus², O. Olaitan³, R. Forbes⁴
¹UNOS, Richmond, VA, ²University of Maryland School of Medicine, Baltimore, MD, ³Rush University Medical Center, Chicago, IL, ⁴Vanderbilt University Medical Center, Nashville, TN
*Purpose: Donation Service Area (DSA) and OPTN Region were removed from pancreas allocation on 3/15/21 and replaced with a 250 nautical mile (NM) fixed circle…

« Previous Page
1
…
3
4
5
6
7
…
190
Next Page »